FDA Issues First-of-Its Kind Guidance on Expectations for Drug Manufacturing 483 Responses

March 19, 2026

Our FDA: Compliance & Enforcement Team explores the U.S. Food and Drug Administration’s new draft guidance on responding to FDA Form 483 observations at the conclusion of an inspection….
By: Alston & Bird

FDA Issues First-of-Its Kind Guidance on Expectations for Drug Manufacturing 483 Responses

Canada’s Defence Industrial Strategy: What You Need to Know